[HTML][HTML] Different neutralization profiles after primary SARS-CoV-2 Omicron BA. 1 and BA. 2 infections

I Medits, DN Springer, M Graninger, JV Camp… - Frontiers in …, 2022 - frontiersin.org
Background and Methods The SARS-CoV-2 (severe acute respiratory syndrome
coronavirus 2) Omicron (B. 1.1. 529) variant is the antigenically most distinct variant to date …

[HTML][HTML] Post-vaccination T cell immunity to omicron

H Jacobsen, V Cobos Jiménez, I Sitaras… - Frontiers in …, 2022 - frontiersin.org
In late 2021, the omicron variant of SARS Coronavirus 2 (SARS-CoV-2) emerged and
replaced the previously dominant delta strain. Effectiveness of COVID-19 vaccines against …

Performance of rapid antigen tests to detect symptomatic and asymptomatic SARS-CoV-2 Infection: A prospective cohort study

A Soni, C Herbert, H Lin, Y Yan, C Pretz… - Annals of internal …, 2023 - acpjournals.org
Background: The performance of rapid antigen tests (Ag-RDTs) for screening asymptomatic
and symptomatic persons for SARS-CoV-2 is not well established. Objective: To evaluate …

[HTML][HTML] The epidemiological features of the SARS-CoV-2 Omicron subvariant BA. 5 and its evasion of the neutralizing activity of vaccination and prior infection

D Tian, W Nie, Y Sun, Q Ye - Vaccines, 2022 - mdpi.com
From December 2021 to May 2022, the Omicron BA. 1 and BA. 2 subvariants successively
became the most dominant strains in many countries around the world. Subsequently …

Research progress in spike mutations of SARS‐CoV‐2 variants and vaccine development

X He, C He, W Hong, J Yang… - Medicinal Research …, 2023 - Wiley Online Library
Abstract The coronavirus disease 2019 (COVID‐19) pandemic can hardly end with the
emergence of different variants over time. In the past 2 years, several variants of severe …

[HTML][HTML] Electrostatic interactions are the primary determinant of the binding affinity of SARS-CoV-2 spike RBD to ACE2: A computational case study of omicron …

P Sang, YQ Chen, MT Liu, YT Wang, T Yue… - International Journal of …, 2022 - mdpi.com
To explore the mechanistic origin that determines the binding affinity of SARS-CoV-2 spike
receptor binding domain (RBD) to human angiotensin converting enzyme 2 (ACE2), we …

[HTML][HTML] Evolution of SARS-CoV-2 in Spain during the first two years of the pandemic: circulating variants, amino acid conservation, and genetic variability in structural …

P Troyano-Hernáez, R Reinosa, Á Holguín - International Journal of …, 2022 - mdpi.com
Monitoring SARS-CoV-2's genetic diversity and emerging mutations in this ongoing
pandemic is crucial to understanding its evolution and ensuring the performance of COVID …

[HTML][HTML] Alveolar macrophages: Achilles' heel of SARS-CoV-2 infection

Z Wang, S Li, B Huang - Signal Transduction and Targeted Therapy, 2022 - nature.com
Abstract The coronavirus disease 2019 (COVID-19) pandemic has caused more than 6.3
million deaths to date. Despite great efforts to curb the spread of severe acute respiratory …

[HTML][HTML] COVID-19 and the immune response: A multi-phasic approach to the treatment of COVID-19

T Sapir, Z Averch, B Lerman, A Bodzin… - International Journal of …, 2022 - mdpi.com
Severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) is a viral agent that causes
Coronavirus disease 2019 (COVID-19), a disease that causes flu-like symptoms that, when …

Competition of SARS-CoV-2 variants on the pandemic transmission dynamics

J Chen, C Gu, Z Ruan, M Tang - Chaos, Solitons & Fractals, 2023 - Elsevier
SARS-CoV-2 has produced various variants during its ongoing evolution. The competitive
behavior driven by the co-transmission of these variants has influenced the pandemic …